Clinical Trial Update: OH2 Injection in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This update notes a Phase 1/Phase 2 trial of OH2 Injection for solid tumors and melanoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• OH2 Injection

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Solid Tumor, Melanoma | Phase 1, Phase 2 | Status: RECRUITING